A Clinical Study Comparing Two Ayurvedic Oil Treatments for Uterine Prolapse Management

A Randomized Comparative Clinical Trial on the Efficacy of Udumbara Palasha Taila and Mrunaladi Taila for Yoni Pichu & Nabhipurana in the Management of Yonibhramsha - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/06/112483

Enrollment

Registered

2026-06-11

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N819- Female genital prolapse, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients complaining of Yoni-bhramsha having any two of the following symptoms: Patient clinically diagnosed 1st and 2 nd degree uterine prolapse associated with or without cystocele and rectocele. Patient with complaints of vaginal discharge, feeling of heaviness in genital region, disturbances in micturition, low back pain, constipation, lower abdominal pain, lack of sexual satisfaction. 2. Patients of age group 25-65 years.

Exclusion criteria

Exclusion criteria: 1. Patient having only cystocele and rectocele. 2. Patients clinically diagnosed with 3rd degree uterine prolapse. 3. Pregnant women. 4. Patient with decubitus ulcer. 4. Known case of chronic and metabolic disorder like diabetes mellitus, hypothyroid, bronchial asthma, lung disease, tuberculosis, hypertension, muscular dystrophy, severe anemia, jaundice, skin disorder etc. 5. Known case of genital tract infection i.e., pelvic inflammatory diseases, cervicitis, HBsAg, HIV, etc., or who are under treatment of same. 6. Patient having any benign and malignant growth of genital tract like Bartholin cyst, polyp, fibroid, Gartner cyst, carcinomatous growth etc. 7. Psychologically unstable patient. 8. Patient with any history of allergy. 9. Patient with any surgical history of the genital tract.

Design outcomes

Primary

Measure	Time frame
Changes in POP-Q-SCALE scores.Timepoint: at baseline, 4 weeks & 8 weeks	—

Secondary

Measure	Time frame
Change in Pelvic Floor Distress Inventory 22 (PFDI-22) scores; Change in Pelvic Floor Impact Questionnaire 7 (PFIQ-7) scores; Improvement in associated symptoms/features.Timepoint: at baseline, 4 weeks & 8 weeks	—

Countries

India

Contacts

Public ContactDr Bharathi kumaramangalam

NATIONAL INSTITUTE OF AYURVEDA, JAIPUR RAJASTHAN

baruhunt@gmail.com9799997940

Outcome results